University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, University of California, Los Angeles (UCLA) - Department of Medicine Statistics Core, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, University Hospital Essen - Department of Urology, Technische Universität München (TUM) - Department of Nuclear Medicine, University of Duisburg-Essen - Department of Nuclear Medicine, Peter MacCallum Cancer Centre, University Hospital Heidelberg - Department of Nuclear Medicine, Excel Diagnostics and Nuclear Oncology Center, Technische Universität München (TUM) - Department of Urology, University Hospital Heidelberg - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, Technische Universität München (TUM) - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Ahmanson Translational Theranostics Division, Technische Universität München (TUM) - Department of Nuclear Medicine, UCLA Medical Center - Department of Urology, Excel Diagnostics and Nuclear Oncology Center, Heidelberg University - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Department of Medicine Statistics Core, University of Duisburg-Essen - Department of Nuclear Medicine, University of California, Los Angeles (UCLA) - Department of Molecular and Medical Pharmacology (DMMP), Peter MacCallum Cancer Centre, University of Duisburg-Essen - Department of Nuclear Medicine and Technische Universität München (TUM) - Department of Nuclear Medicine